Document is current
Any future updates will be listed below
-
Authors
Campbell, Ian W.
Brand, Kerstin M. G.
Gottwald-Hostalek, Ulrike
Dettenbach, Julian
-
Funding
Funding for this research was provided by:
The healthcare business of Merck KGaA, Darmstadt, Germany (CrossRef Funder ID: 10.13039/100009945)
- License Information
-
More Information
Article History
Received: 3 February 2026
Accepted: 31 March 2026
First Online: 13 April 2026
Declarations
:
: Ian W Campbell reports past honoraria for work on advisory boards and lecturing from GSK, J&J, Lilly, the healthcare business of Merck KGaA, Darmstadt, Germany, Sanofi and Takeda. Julian Dettenbach and Kerstin MG Brand are existing and Ulrike Gottwald-Hostalek is retired full-time employee of the healthcare business of Merck KGaA, Darmstadt, Germany. The views expressed in this article are the authors’ own and do not necessarily reflect the views of their respective companies.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
